Company news
Stevanato Group S.p.a. (NYSE:STVN) news
Every Stevanato Group S.p.a. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Stevanato Group to Participate in Two Upcoming Investor Conferences
September 8, 2026
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
August 4, 2026
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
July 30, 2026
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
July 21, 2026
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
June 8, 2026
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting
June 4, 2026
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
June 3, 2026
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
May 7, 2026
Stevanato Group to Participate in Three Upcoming Investor Conferences
May 4, 2026
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
March 5, 2026
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
March 4, 2026
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
February 19, 2026
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
November 6, 2025
Stevanato Group to Participate in Upcoming Investor Conferences
October 31, 2025
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025
October 22, 2025
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
October 21, 2025
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
August 5, 2025
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
July 23, 2025
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025
July 22, 2025
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
May 8, 2025
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
March 11, 2025
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
March 6, 2025
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
February 24, 2025